Moxiclav (Amoxicillin, Clavulanic Acid)

Amoxicillin/clavulanic acid, the active ingredient in Moxiclav, is a beta‑lactam antibiotic; beta‑lactamase inhibitor combination presented as an oral formulation for oral use. It treats a range of bacterial infections such as respiratory, urinary and skin infections in adults and children. GNH USA supplies Moxiclav as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxiclav is a broad‑spectrum antibacterial that targets common bacterial pathogens in the following conditions:

Upper respiratory tract infections: eliminates causative bacteria and relieves symptoms. Sinusitis: resolves infection and reduces sinus inflammation. Otitis media: clears middle‑ear bacterial infection. Community‑acquired pneumonia: treats typical bacterial pneumonia agents. Urinary tract infections: eradicates susceptible uropathogens. Skin and soft tissue infections: combats bacterial skin infections.

Adverse reactions may occur with Moxiclav use.

Common Side Effects: - Diarrhea - Nausea - Vomiting - Rash

Serious or Rare Side Effects: - Anaphylaxis (severe allergic reaction) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Clostridioides difficile‑associated colitis - Elevated liver enzymes or hepatic injury

Before prescribing Moxiclav, consider the following precautions:

Assess allergy history: verify no known hypersensitivity to penicillins or beta‑lactamase inhibitors. Monitor renal function: dose adjustment may be required in renal impairment. Use with caution in hepatic disease: monitor liver enzymes regularly. Avoid in pregnancy unless benefits outweigh risks: limited safety data are available. Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture.

Moxiclav can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Allopurinol: risk of severe skin reactions. - Methotrexate: increased methotrexate toxicity. - Oral contraceptives: reduced hormonal effectiveness.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR. - Probenecid: may raise amoxicillin plasma levels. - Antacids containing aluminum or magnesium: can diminish absorption of amoxicillin.